Simultaneous Pharmacokinetic Modeling of Gentamicin, Tobramycin and Vancomycin Clearance from Neonates to Adults: Towards a Semi-physiological Function for Maturation in Glomerular Filtration

被引:77
作者
De Cock, Roosmarijn F. W. [1 ]
Allegaert, Karel [2 ]
Brussee, Janneke M. [1 ]
Sherwin, Catherine M. T. [3 ,4 ]
Mulla, Hussain [5 ]
de Hoog, Matthijs [6 ]
van den Anker, Johannes N. [6 ,7 ]
Danhof, Meindert [1 ]
Knibbe, Catherijne A. J. [1 ,8 ]
机构
[1] Leiden Univ, Div Pharmacol, LACDR, Leiden, Netherlands
[2] Univ Hosp Leuven, Neonatal Intens Care Unit, Leuven, Belgium
[3] Univ Utah, Sch Med, Div Clin Pharmacol, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Pediat, Clin Trials Off, Salt Lake City, UT USA
[5] Univ Hosp Leicester, Dept Pharm, Leicester, Leics, England
[6] Erasmus MC Sophia Childrens Hosp, Dept Pediat Intens Care, Rotterdam, Netherlands
[7] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA
[8] St Antonius Hosp, Dept Clin Pharm, NL-3430 EM Nieuwegein, Netherlands
关键词
antibiotics; developmental changes; glomerular filtration; pediatric age range; RENAL-FUNCTION; SERUM CREATININE; POPULATION PHARMACOKINETICS; CHILDREN YOUNGER; ENZYMATIC METHOD; REFERENCE VALUES; INFANTS; PREDICTION; ONTOGENY; ELIMINATION;
D O I
10.1007/s11095-014-1361-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose Since glomerular filtration rate (GFR) is responsible for the elimination of a large number of water-soluble drugs, the aim of this study was to develop a semi-physiological function for GFR maturation from neonates to adults. Methods In the pharmacokinetic analysis (NONMEM VI) based on data of gentamicin, tobramycin and vancomycin collected in 1,760 patients (age 1 day-18 years, bodyweight 415 g-85 kg), a distinction was made between drug-specific and system-specific information. Since the maturational model for clearance is considered to contain system-specific information on the developmental changes in GFR, one GFR maturational function was derived for all three drugs. Results Simultaneous analysis of these three drugs showed that maturation of GFR mediated clearance from preterm neonates to adults was best described by a bodyweight-dependent exponent (BDE) function with an exponent varying from 1.4 in neonates to 1.0 in adults (Cl-GFR= Cl-drug*(BW/4 kg)(BDE) with BDE = 2.23*BW-0.065). Population clearance values (Cl-drug) for gentamicin, tobramycin and vancomycin were 0.21, 0.28 and 0.39 L/h for a full term neonate of 4 kg, respectively. Discussion Based on an integrated analysis of gentamicin, tobramycin and vancomycin, a semi-physiological function for GFR mediated clearance was derived that can potentially be used to establish evidence based dosing regimens of renally excreted drugs in children.
引用
收藏
页码:2643 / 2654
页数:12
相关论文
共 44 条
[1]  
Administration FaD, 2000, GUID IND E 11 CLIN I
[2]   Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I [J].
Alcorn, J ;
McNamara, PJ .
CLINICAL PHARMACOKINETICS, 2002, 41 (12) :959-998
[3]   Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method [J].
Allegaert, Karel ;
Kuppens, Maike ;
Mekahli, Djalila ;
Levtchenko, Elena ;
Vanstapel, Florent ;
Vanhole, Christine ;
van den Anker, John N. .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (09) :1678-1681
[4]   Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance [J].
Anderson, Brian J. ;
Allegaert, Karel ;
Van den Anker, John N. ;
Cossey, Veerle ;
Holford, Nicholas H. G. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) :75-84
[5]   Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations [J].
Bartelink, Imke H. ;
Rademaker, Carin M. A. ;
Schobben, Alfred F. A. M. ;
van den Anker, John N. .
CLINICAL PHARMACOKINETICS, 2006, 45 (11) :1077-1097
[6]   Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients Towards Individualized Dosing [J].
Bartelink, Imke H. ;
Boelens, Jaap J. ;
Bredius, Robbert G. M. ;
Egberts, Antoine C. G. ;
Wang, Chenguang ;
Bierings, Marc B. ;
Shaw, Peter J. ;
Nath, Christa E. ;
Hempe, George ;
Zwaveling, Juliette ;
Danhof, Meindert ;
Knibbe, Catherijne A. J. .
CLINICAL PHARMACOKINETICS, 2012, 51 (05) :331-345
[7]   Modelling and simulation as research tools in paediatric drug development [J].
Bellanti, Francesco ;
Della Pasqua, Oscar .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 :S75-S86
[8]   Reference values for serum creatinine in children younger than 1 year of age [J].
Boer, Dirk P. ;
de Rijke, Yolanda B. ;
Hop, Wim C. ;
Cransberg, Karlien ;
Dorresteijn, Eiske M. .
PEDIATRIC NEPHROLOGY, 2010, 25 (10) :2107-2113
[9]   Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated?: A survey of the literature from 2002 to 2004 [J].
Brendel, Karl ;
Dartois, Celine ;
Comets, Emmanuelle ;
Lemenuel-Diot, Annabelle ;
Laveille, Christian ;
Tranchand, Brigitte ;
Girard, Pascal ;
Laffont, Celine M. ;
Mentre, France .
CLINICAL PHARMACOKINETICS, 2007, 46 (03) :221-234
[10]   The influences of renal function and maturation on vancomycin elimination in newborns and infants [J].
Capparelli, EV ;
Lane, JR ;
Romanowski, GL ;
McFeely, EJ ;
Murray, W ;
Sousa, P ;
Kildoo, C ;
Connor, JD .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (09) :927-934